Science & Enterprise subscription

Follow us on Twitter

  • As the U.S. enters its Independence Day in the midst of its worst-ever pandemic, a divided public most trusts its h… https://t.co/umw9fDWuvJ
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Health Agencies Trusted for Covid-19 Info https://t.co/RerieMYQgn #Science #Business
    about 2 days ago
  • Change the name of the Washington NFL team? A respondent to @joshtpm has a brilliant idea ... Washington Dukes, for… https://t.co/J9P4LKG2PT
    about 3 days ago
  • A medical software team designed a mobile app that records and analyzes a person's sounds and sleep positions to de… https://t.co/NB99HQUWpC
    about 3 days ago
  • New post on Science and Enterprise: Mobile App Screens for Sleep Apnea https://t.co/N8gTn2zWhe #Science #Business
    about 3 days ago

Please share Science & Enterprise

Engineered Fluid Devised for Lubricating Joint Cartilage

Jennifer Elisseeff (Johns Hopkins University)

Jennifer Elisseeff (Johns Hopkins University)

18 August 2014. Biomedical engineers at Johns Hopkins University in Baltimore developed a synthetic lubrication fluid for natural or artificial joints in the body that emulates the properties of natural substances. A team led by Johns Hopkins medical professor Jennifer Elisseeff published its results earlier this month in the journal Nature Materials (paid subscription required).

Knees, hips, and elbow joints have a naturally-produced lubricant called hyaluronic acid found in the joints’ synovial fluid, a viscous substance that resembles motor oil. Hyaluronic acid also helps joints protect against inflammation and metabolic damage.

As people age or the joints become damaged, however, concentrations of hyaluronic acid become lower, leading to pain. The lower concentrations are believed to result from the lack of a key protein that binds hyaluronic acid to joint surfaces.

Some patients with osteoarthritis, the common wear and tear on joints as people age, try injections of hyaluronic acid to restore the joints’ natural lubrication, a treatment known as viscosupplementation. The technique, however, often requires several weeks to take effect and in a systematic review of clinical trials, showed little benefit for relieving pain or improving joint function. The review also showed viscosupplementation increases the risk for adverse effects.

One of the reasons for the limited benefit of viscosupplementation is the inability of joints to retain hyaluronic acid, which gets washed away by the body’s natural cleansing process. Elisseeff and colleagues sought to remedy this property by devising peptides, short chains of amino acid molecules, that are tethered to biocompatible polymers, but also bind with hyaluronic acid molecules.

The Johns Hopkins team tested these binding peptides with both natural and artificial cartilage samples in the lab, and later in the knees of lab rats. The tests used the binding peptides with polyethylene glycol, a common biocompatible polymer, to connect the hyaluronic acid with cartilage tissue in both the samples and animal tests.

The researchers found the engineered binding peptides/hyaluronic acid compound reduces friction as well as natural hyaluronic acid. When injected into the knees of lab rats, the tests show the engineered compound lasts 12 times as long as natural hyaluronic acid. The results suggest the compound could be a useful addition to viscosupplementation, as well as a coating for replacement joints.

“What I like about this concept,” says Elisseeff in a university statement, “is that we’re mimicking natural functions that are lost using synthetic materials.” Elisseeff and a colleague filed a patent application last year covering biomaterials combining binding peptides with biocompatible polymers for retaining hyaluronic acid and other tissue engineering applications.

Read more:

*     *     *

Please share Science & Enterprise ...

Comments are closed.